Mark W. Kroll - Aug 15, 2022 Form 4 Insider Report for HAEMONETICS CORP (HAE)

Role
Director
Signature
/s/ Thomas V. Powers, attorney-in-fact for Dr. Kroll
Stock symbol
HAE
Transactions as of
Aug 15, 2022
Transactions value $
-$590,859
Form type
4
Date filed
8/16/2022, 04:33 PM
Previous filing
Aug 8, 2022
Next filing
Mar 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HAE Common Stock Sale -$591K -8.02K -33.06% $73.71 16.2K Aug 15, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.41 to $74.25, inclusive. The reporting person undertakes to provide to Haemonetics Corporation ("Haemonetics"), any security holder of Haemonetics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 This number includes unvested restricted stock units previously reported.